Moreover, detecting markers, including Aβ42 (Aβ1–42), total-Tau (tTau), and p-Tau-181, in CSF is paving the way for AD diagnosis based on biomarkers [73]. The gene discussed is MAPT; the disease is Alzheimer disease.